RedHill Biopharma Reports Operational Highlights and Fourth

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational...

Related Keywords

United Arab Emirates , California , United States , South Korea , Israel , Qatar , United Kingdom , Kuwait , South Africa , Saudi Arabia , Bahrain , Woman , Americans , South Korean , American , Amber Fennell , Dror Ben Asher , Redhill Biopharma , Bryan Gibbs , Adi Frish , Micha Ben Chorin , Kukbo Co , California Medicaid Health Care , Ghassan Aboud Group , Redhill Biopharma Ltd , Nasdaq , National Medicare Part , Development Expenses , Company Annual Report On Form , Exchange Commission , Company Expanded Access Program , Korea Kukbo Co , Gaelan Medical Trade , Gulf Cooperation Council Region Saudi Arabia , Business Development , Chief Executive Officer , Ben Chorin , Chief Financial Officer , Administrative Expenses , Cash Used , Operating Activities , Cash Provided , Financing Activities , Net Cash Used , Gaelan Medical , Drug Price Competition , Patent Term Restoration Act , Hatch Waxman Act , Gulf Cooperation Council , Medicaid Health Care , Contract Drug List , Drug Products , Therapeutic Equivalence Evaluations , Hazard Ratio , Nontuberculous Mycobacteria , Webcast Information , Hill Biopharma , Private Securities Litigation Reform Act , Expanded Access Program , Annual Report , Ended December ,